BioCentury
ARTICLE | Finance

Next phase for Phase4

Phase4 Ventures spins out from Nomura, plans new Euro focused biotech fund

February 14, 2011 8:00 AM UTC

Phase4 Ventures expects to focus more on European investment following its spinout from Nomura. The firm will be raising its first independent fund sometime over the next 12 months.

The new firm expects to invest upwards of 50% in Europe, while under Nomura that proportion was about 35%, Managing Partner Denise Pollard-Knight told Ebb & Flow...